Skip to main content
SpringerLink
Log in

Clinical phenotype, prognosis and mitochondrial DNA mutation load in mitochondrial encephalomyopathies

  • Original Paper
  • Published:
Journal of Biomedical Science

Abstract

We studied 42 individuals, including 8 patients with either complete or partial syndrome of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), 8 patients with either complete or partial syndrome of myoclonic epilepsy with ragged-red fibers (MERRF) and 26 maternal family members who carried either the A3243G or A8344G mutation of mitochondrial DNA (mtDNA). Clinical manifestations and prognosis were followed up in the patients harboring the A3243G or A8344G mutation. The relationship between clinical features and proportions of mutant mtDNAs in muscle biopsies, blood cells and/or hair follicles was studied. In the 8 regularly followed patients with the A3243G mutation, 4 died within 1 month to 7 years due to status epilepticus and/or recurrent stroke-like episodes. Two patients developed marked mental deterioration and 2 remained stationary. All of the patients harboring the A8344G mutation were stable or deteriorated slightly, except for 1 patient who died due to brain herniation after putaminal hemorrhage. The A3243G and A8344G mtDNA mutations were heteroplasmic in the muscle biopsies, blood cells and hair follicles of both the probands and their maternal family members. The mean proportion of A3243G mutant mtDNA in the muscle biopsies of the patients with MELAS syndrome (68.5 ± 21.3%, range 33–92%) was significantly higher than that of the asymptomatic family members (37.1 ± 12.6%, range 0–51%). The average proportions of A8344G mutant mtDNA in the muscle biopsies (90.1 ± 3.9%, range 89–95%) and hair follicles (93.9 ± 6.4%, range 84–99%) of the patients with MERRF syndrome were also significantly higher than those of the asymptomatic family members (muscle: 40.3 ± 39.5%, range 1–80%; hair follicles: 51.0 ± 44.5%, range 0.1–82%). We concluded that measurement of the proportion of mutant mtDNA in muscle biopsies may provide useful information in the identification of symptomatic patients with mitochondrial encephalomyopathies. For patients with the A3243G mutation, the prognosis was related to status epilepticus and the number of recurrent stroke-like episodes and was much worse than for patients with the A8344G mutation of mtDNA, who had stable or slowly deteriorating clinical courses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chen RS, Huang CC, Chu NS, Chu CC, Shih KD, Pang CY, Wei YH. Tissue distribution of mutant mitochondrial DNA in a patient with MERRF syndrome. Muscle Nerve 94:519–521;1996.

    Article  Google Scholar 

  2. Chen RS, Huang CC, Lee CC, Wai YY, Hsi MS, Pang CY, Wei YH. Overlapping syndrome of MERRF and MELAS: Molecular and neuroradiological studies. Acta Neurol Scand 87:494–498;1993.

    PubMed  Google Scholar 

  3. Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. Molecular pathology of MELAS and MERRF: The relationship between mutation load and clinical phenotypes. Brain 120:1713–1721;1997.

    Article  PubMed  Google Scholar 

  4. Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring. Brain 121:1889–1894;1998.

    Article  PubMed  Google Scholar 

  5. Ciafaloni E, Ricci E, Shanske S, Moraes CT, Silvestri G, Hirano M, Simonetti S, Angelini C, Donati MA, Garcia C. MELAS: Clinical features, biochemistry, and molecular genetics. Ann Neurol 31:391–398;1992.

    Article  PubMed  Google Scholar 

  6. DiMauro S. Mitochondrial encephalomyopathies. In Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, Kunkel LM, eds. The Molecular and Genetic Basis of Neurological Disease. Boston, Butterworth-Heinemann, 665–694;1993.

    Google Scholar 

  7. Fang W, Huang CC, Chu NS, Lee CC, Chen RS, Pang CY, Shih KD, Wei YH. Myoclonic epilepsy with ragged-red fibers (MERRF) syndrome: Report of a Chinese family with mitochondrial DNA point mutation in tRNALys gene. Muscle Nerve 17:52–57;1994.

    Article  PubMed  Google Scholar 

  8. Fang W, Huang CC, Lee CC, Cheng SY, Pang CY, Wei YH. Ophthalmologic manifestations in MELAS syndrome. Arch Neurol 53:977–980;1993.

    Google Scholar 

  9. Goto Y, Horai S, Matsuoka T, Koga Y, Nihei K, Kobayashi M, Nonaka I. Mitochondrial myopathy encephalopathy, lactic acidosis and stroke-like episodes (MELAS): A correlative study of the clinical features and mitochondrial DNA mutation. Neurology 42:545–550;1992.

    PubMed  Google Scholar 

  10. Goto Y, Nonaka I, Horai S. A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348:651–653;1990.

    Article  PubMed  Google Scholar 

  11. Hammans SR, Sweeney MG, Brockington M, Lennox GG, Lawton NF, Kennedy CR, Morgan-Hughes JA, Harding AE. The mitochondrial DNA transfer RNA(Lys)A→G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibers (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain 116:617–632;1993.

    PubMed  Google Scholar 

  12. Hammans SR, Sweeney MG, Hanna MG. The mitochondrial DNA transfer RNALeu (UUR) A3243G mutation. A clinical and genetic study. Brain 118:721–734;1995.

    PubMed  Google Scholar 

  13. Hasegawa H, Matsuoka T, Goto YI, Nonaka I. Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. Ann Neurol 29:601–605;1991.

    Article  PubMed  Google Scholar 

  14. Hirano M, Ricci E, Koenigsberger MR, Defendini R, Pavlakis SG, DeVivo DC, DiMauro S, Rowland LP. MELAS: An original case and clinical criteria for diagnosis. Neuromuscul Disord 2:125–135;1992.

    Article  PubMed  Google Scholar 

  15. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 46:428–433;1990.

    PubMed  Google Scholar 

  16. Huang CC, Chen RS, Chen CM, Wang HS, Lee CC, Pang CY, Hsu HS, Lee HC, Wei YH. MELAS syndrome with mitochondrial tRNALeu(UUR) gene mutation in a Chinese family. J Neurol Neurosurg Psychiatry 57:586–589;1994.

    PubMed  Google Scholar 

  17. Huang CC, Chen RS, Chu NS, Pang CY, Wei YH. Random mitotic segregation of mitochondrial DNA in MELAS syndrome. Acta Neurol Scand 93:198–202;1996.

    PubMed  Google Scholar 

  18. Huang CC, Wai YY, Chu NS, Liou CW, Pang CY, Shih KD, Wei YH. Mitochondrial encephalomyopathies: CT and MRI findings and correlations with clinical features. Eur Neurol 35:199–205; 1995.

    PubMed  Google Scholar 

  19. Kobayashi Y, Momoi MY, Tominaga K, Momoi T, Nihei K, Yanagisawa M, Kagawa Y, Ohta S. A point mutation in the mitochondrial tRNALeu(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem Biophys Res Commun 173:816–822;1990.

    Article  PubMed  Google Scholar 

  20. Koo B, Becker LE, Chuang S, Merante F, Robinson BH, MacGregor D, Tein I, Ho VB, McGreal DA, Wherrett JR. Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS): Clinical, radiological, pathological, and genetic observations. Ann Neurol 34:25–32;1993.

    Article  PubMed  Google Scholar 

  21. Larsson NG, Tulinius MH, Holme E, Oldfors A, Andersen O, Wahlstrom J, Aasly J. Segregation and manifestations of the mtDNA tRNA-(Lys) A→G(8344) mutation of myoclonus epilepsy and ragged-red fiber (MERRF) syndrome. Am J Hum Genet 51:1201–1212;1992.

    PubMed  Google Scholar 

  22. Lee ML, Chaou WT, Yang AD, Jong YJ, Tsai JL, Pang CY, Wei YH. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS): Report of a sporadic case and review of the literature. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 35:148–156;1994.

    PubMed  Google Scholar 

  23. Li JY, Kong KW, Chang MH, Cheung SC, Lee HC, Pang CY, Wei YH. MELAS syndrome associated with a tandem duplication in the D-loop of mitochondrial DNA. Acta Neurol Scand 93:450–455;1996.

    PubMed  Google Scholar 

  24. Liou CW, Huang CC, Chee ECY, Jong YJ, Tsai JL, Pang CY, Lee HC, Wei YH. MELAS syndrome: Correlation between clinical features and molecular genetic analysis. Acta Neurol Scand 90:354–359;1994.

    PubMed  Google Scholar 

  25. Matsuoka T, Goto Y, Yoneda M, Nonaka I. Muscle histopathology in myoclonus epilepsy with ragged-red fibers (MERRF). J Neurol Sci 106:193–198;1991.

    PubMed  Google Scholar 

  26. Nonaka I. Mitochondrial diseases. Curr Opin Neurol Neurosurg 5:622–632;1992.

    PubMed  Google Scholar 

  27. Ozawa M, Goto Y, Sakuta R, Tanno Y, Tsuji S, Nonaka I. The 8344 mutation in mitochondrial DNA: A comparison between the proportion of mutant DNA and clinico-pathologic findings. Neuromuscul Disord 5:483–488;1995.

    Article  PubMed  Google Scholar 

  28. Pang CY, Huang CC, Yen MY, Wang EK, Kao KP, Chen SS, Wei YH. Molecular epidemiologic study of mitochondrial DNA mutations in patients with mitochondrial diseases in Taiwan. J Formos Med Assoc 98:326–334;1999.

    PubMed  Google Scholar 

  29. Sakuta R, Nonaka I. Vascular involvement in mitochondrial myopathy. Ann Neurol 25:594–601;1989.

    Article  PubMed  Google Scholar 

  30. Schon EA, Bonilla E, DiMauro S. Mitochondrial DNA mutations and pathogenesis (review). J Bioenerg Biomembr 29:131–149;1997.

    Google Scholar 

  31. Seibel P, Degoul F, Bonne G, Romero N, Franois D, Paturneau-Jouas M, Zeigler F, Eymard B, Fardeau M, Marsac C, Kadenbach B. Genetic, biochemical and pathophysiological characterization of a family mitochondrial encephalomyopathy (MERRF). J Neurol Sci 105:217–224;1991.

    Article  PubMed  Google Scholar 

  32. Servidei S. Mitochondrial encephalomyopathies: Gene mutation. Neuromuscul Disord 8:8–9;1998.

    Google Scholar 

  33. Shih KD, Yen TC, Pang CY, Wei YH. Mitochondrial DNA mutation in a Chinese family with myoclonic epilepsy and ragged-red fiber disease (MERRF). Biochem Biophys Res Commun 174:1109–1116;1991.

    Article  PubMed  Google Scholar 

  34. Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell 61:931–937;1990.

    Article  PubMed  Google Scholar 

  35. Silvestri G, Ciafaloni E, Santorelli FM, Shanske S, Servidei S, Graf WD, Sumi M, DiMauro S. Clinical features associated with the A→G transition at nucleotide 8344 of mtDNA (MERRF mutation). Neurology 43:1200–1206;1993.

    PubMed  Google Scholar 

  36. Tanno Y, Yoneda M, Nonaka I, Tanaka K, Miyatake T, Tsuji S. Quantitation of mitochondrial DNA carrying tRNALys mutation in MERRF patients. Biochem Biophys Res Commun 179:880–885;1991.

    Article  PubMed  Google Scholar 

  37. Vilarinho L, Sanforelli FM, Coelho I, Rodrigues L, Maia M, Barafa I, Cabral P, Dionisio A, Costa A, Guimaraes A, DiMauro S. The mitochondrial DNA A3243G mutation in Portugal: Clinical and molecular studies in 5 families. J Neurol Sci 163:168–174;1999.

    PubMed  Google Scholar 

  38. Yang CC, Hwang CC, Pang CY, Wei YH. Mitochondrial myopathy with predominant respiratory dysfunction in a patient with A3243G mutation in the mitochondrial tRNALeu(UUR) gene. J Formos Med Assoc 91:715–719;1998.

    Google Scholar 

  39. Yang CY, Lam HC, Lee HC, Wei YH, Lu CC, Han TM, Tsai JL, Chuang YH, Lee JK. MELAS syndrome associated with diabetes mellitus and hyperthyroidism: A case report from Taiwan. Clin Endocrinol (Oxf) 43:235–239;1995.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Chang Gung Memorial Hospital and University, Taiwan, ROC

    Chin-Chang Huang MD, Hung-Chou Kuo, Chen-Che Chu & Yi-Shing Ma

  2. Department of Neurology, Chang Gung Memorial Hospital, Taiwan, ROC

    Chia-Wei Liou

  3. Department of Biochemistry and Center for Cellular and Molecular Biology, National Yang-Ming University, Taipei, Taiwan, ROC

    Yau-Huei Wei

Authors
  1. Chin-Chang Huang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hung-Chou Kuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chen-Che Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chia-Wei Liou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yi-Shing Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yau-Huei Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, CC., Kuo, HC., Chu, CC. et al. Clinical phenotype, prognosis and mitochondrial DNA mutation load in mitochondrial encephalomyopathies. J Biomed Sci 9, 527–533 (2002). https://doi.org/10.1007/BF02254979

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02254979

Key Words

Search

Navigation